(Q43987270)

28 November 2017

title

Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study (English)

1 reference

Camilo de la Fuente-Sandoval

28 November 2017

1 reference

1 reference

1

object named as

Camilo de la Fuente-Sandoval

0 references

Ariel Graff-Guerrero

6

object named as

Ariel Graff-Guerrero

0 references

Pablo León-Ortiz

2

object named as

Pablo León-Ortiz

0 references

author name string

Camilo de la Fuente-Sandoval

1

1 reference

28 November 2017

Pablo León-Ortiz

2

1 reference

28 November 2017

Mariana Azcárraga

3

1 reference

28 November 2017

Rafael Favila

4

1 reference

28 November 2017

Sylvana Stephano

5

1 reference

28 November 2017

language of work or name

1 reference

17 April 2012

1 reference

The International Journal of Neuropsychopharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

16

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

471-475

1 reference

Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

The dopamine hypothesis of schizophrenia: version III--the final common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Gating of information flow within the limbic system and the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Increased synaptic dopamine function in associative regions of the striatum in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

The prodromal phase of first-episode psychosis: past and current conceptualizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

7 January 2021

Differential changes in glutamatergic transmission via N-methyl-D-aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

7 January 2021

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000314

7 January 2021

10.1017/S1461145712000314

Identifiers

DOI

1 reference

28 November 2017

1 reference